Clinical trials
Phase 2 trials in North Macedonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ablynx, a Sanofi company | 3 |
| BioCryst Pharmaceuticals | 2 |
| Dianthus Therapeutics | 2 |
| Immunic AG | 2 |
| KalVista Pharmaceuticals, Ltd. | 2 |
| Pharming Technologies B.V. | 2 |
| Alnylam Pharmaceuticals | 1 |
| Amgen | 1 |
| CSL Behring | 1 |
| Cellaion SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angioedemas, Hereditary | 5 |
| Arthritis, Rheumatoid | 4 |
| Breast Neoplasms | 2 |
| Multiple Sclerosis | 2 |
| Neoplasm Metastasis | 2 |
| Acute-On-Chronic Liver Failure | 1 |
| Angioedema | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.